US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 3.7100
  • +0.0900+2.49%
Close May 28 16:00 ET
  • 3.6700
  • -0.0400-1.08%
Post 18:10 ET
3.49MMarket Cap0.29P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avenue Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-1.16K

-1295.35%
Analyst Rating

Buy

Apr 28, 2024

Avenue Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
--2021/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
--2021/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Avenue Therapeutics Earnings Reports

  • Avenue Therapeutics | 10-Q: Quarterly report

    May 15 15:26

  • Avenue Therapeutics | 10-K: Annual report

    Mar 18 15:23

  • Avenue Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 15:15

  • Avenue Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 15:25

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg